Vice President, Research and Development
Jody Berry, Ph.D. has been the Vice President, Research and Development at OraSure since April 2018. Dr. Berry possesses 20 years of industry experience designing and developing immunoassays with a strong focus on infectious disease diagnostics.
Most recently, he worked at Grifols Diagnostic Solutions, where he served as Director of Research, Immunochemistry, leading teams in the development of Infectious Disease Immunodiagnostic assays and Biomarker Discovery.
Prior to that, Dr. Berry held senior R & D roles at Proteos, BD Biosciences, and Cangene after an 8 year career with the Canadian Government, where he founded and/or led research teams that specialized in identifying and developing immunoassay detection methodologies and reagents for infectious diseases.
Dr. Berry has a Bachelor of Science with Honors degree from the Department of Microbiology at the University of Manitoba and a Ph.D. from the Department of Medical Microbiology at the University of Manitoba.
Vice President, Innovation and Technology
Dr. Iwasiow joined DNA Genotek, a subsidiary of OraSure Technologies, in 2006 as a Research & Development Scientist; he has contributed significantly to the company's patent portfolio in numerous areas including nucleic acid stabilization methods and physical sample collection devices.
In 2008 he took on the responsibility of managing the product development team and has advanced his career through Director level roles resulting in his appointment to the Vice President of Research and Development. Under Dr. Iwasiow’s leadership, the Research and Development team contributed to successful 510(k) clearances of the Oragene•Dx collection device, the first non-invasive DNA collection device cleared by the FDA, and he and his team have developed and delivered new chemistries, products and service offerings throughout his years with the company.
Prior to joining DNA Genotek, Dr. Iwasiow completed a post-doctoral fellowship at the National Research Council of Canada in the areas of neurogenesis/neuroprotection and he holds a Ph.D. degree in Cellular and Molecular Medicine from the University of Ottawa.